HIKALNSEHikal Limited· PharmaceuticalsMediumNeutral
Announced Wed, 14 May · 14:40 IST

Hikal Limited has informed the Exchange regarding appointment of Secretarial Auditor and re-appointment of Cost Auditor

Management Changes View source PDF

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hikal Limited's board approved audited financial results for Q4 and FY ending March 31, 2025, with statutory auditor S R B C & Co. LLP issuing an unmodified opinion. Standalone total income for FY25 rose to Rs. 1,864.8 crore from Rs. 1,787.1 crore, with profit after tax increasing to Rs. 90.5 crore from Rs. 69.5 crore, lifting basic EPS to Rs. 7.37 from Rs. 5.64. The board recommended a final dividend of 40% (Rs. 0.80 per share), taking total FY25 dividend to 70% (Rs. 1.40 per share), up from 60% last year. M/s Dhrumil M. Shah & Co. LLP was appointed as Secretarial Auditor for five years (FY26–FY30), and V.J. Talati & Co. as Cost Auditor for FY26. Mr. Sameer Hiremath was redesignated from Managing Director to Vice Chairman & Managing Director.

Likely market impact

Strong operational performance with revenue, profit, and dividend all growing year-on-year is a positive signal for shareholders. The continued environmental matter pending before the Supreme Court remains a key overhang to monitor. Routine auditor appointments and the internal MD redesignation are neutral governance events.